Categories: Wire Stories

ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer

SAN FRANCISCO & SHANGHAI–(BUSINESS WIRE)–ShouTi Inc., a clinical-stage biopharmaceutical company creating world-class small molecule medicines using advanced computational and structure-based technology, today announced the appointment of Ding Ding, Ph.D., as Chief Financial Officer (CFO). Dr. Ding will oversee the company�s investor relations and global financing activities. She joins ShouTi from Credit Suisse, where she served as the head of APAC Healthcare Investment Banking and Capital Markets.

“Dr. Ding is an accomplished financial executive with an exceptional track record in the global healthcare investment banking industry,” said Dr. Raymond Stevens, Ph.D., Chief Executive Officer. “Dr. Ding’s deep financial acumen and expertise both in the United States and in Asia will serve ShouTi well as we advance our pipeline of small molecule medicines for chronic diseases within the metabolic, cardiovascular and pulmonary therapeutic areas. We are thrilled to welcome her to our team, where her contributions will help position ShouTi for significant growth in the years ahead.”

Dr. Ding brings 20 years of experience in healthcare investment banking and equity research in New York, Hong Kong and Shanghai. She began her career in 2001 at UBS Warburg in US healthcare investment banking, and then as a research analyst covering US large cap pharma at Lehman Brothers. In 2010, Dr. Ding rejoined UBS as the head of China healthcare equity research, and then acted as the head of China healthcare investment banking for Barclays before joining Credit Suisse. Dr. Ding received her B.S. from Huazhong University of Science and Technology, MBA in finance from The Wharton School at the University of Pennsylvania, and Ph.D. in pharmacology and neuroscience from the State University of New York.

About ShouTi

ShouTi develops life-changing medicines for patients using advanced computational and structure-based technology. The company’s platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations of biologic and peptide drugs. ShouTi is advancing its clinical-stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. The ShouTi team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables the company’s vision: to design and develop world-class medicines with high patient impact and broad commercial opportunity. For more information, visit www.shoutipharma.com and follow the company on Twitter @ShouTiPharma and LinkedIn.

Contacts

Media:
Ian Stone

Canale Communications

media@shoutipharma.com

Other inquiries:
Melita Sun Jung

Chief Business Officer

info@shoutipharma.com

Alex

Recent Posts

CGTN: China vows continued efforts to build Asia-Pacific community with shared future

BEIJING, CHINA - Media OutReach Newswire - 8 November 2024 - Since its inception more…

11 hours ago

TBS Energi Utama to Acquire Singapore’s Integrated Waste Management Services Provider, Sembcorp Environment Pte. Ltd.

Acquisition Expands TBS’ Regional Waste Management Platform in Indonesia and Singapore, aligning with its TBS2030…

13 hours ago

Score 11 Unbeatable Deals This 11.11 on Shopee with 90% Off Lowest Price Guaranteed

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 8 November 2024 - It’s that time…

15 hours ago

Shenzhen China Wins the World Smart City Award, Demonstrating the Global Influence of Social Intelligent Governance of Mega City

BARCELONA, SPAIN - Media OutReach Newswire - 8 November 2024 - On November 6, Central…

16 hours ago

Singapore – A Trusted Global Supply Chain Management Hub

SINGAPORE - Media OutReach Newswire - 8 November 2024 - Singapore is strengthening its position…

17 hours ago

OPPO Celebrates Global Photography Talent at Paris Photo Fair under the theme of “Dear Life”

PARIS, FRANCE - Media OutReach Newswire – 8 November 2024 - This year, OPPO once…

18 hours ago